ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
16 announcements
Resonance Specialties' postal ballot passed a related-party slump-sale purchase. The resolution to buy KPLL's Mandideep facility for Rs.29.98 crore carried 99.82% support.
Resonance Specialties received a credit rating reaffirmation of 'CRISIL BBB-/Stable' for its bank loan facilities totaling Rs 14 Crore.
Resonance Specialties Limited seeks shareholder approval via postal ballot for the Rs. 29.98 Crore slump sale acquisition of Kaygee Laboratories' Mandideep manufacturing facility.
Resonance Specialties Limited submitted its quarterly shareholding pattern for the period ended December 31, 2025, as required by SEBI regulations.
Resonance Specialties Limited announced that all six resolutions at its 37th Annual General Meeting held on August 4, 2026, were passed by the requisite majority.
Resonance Specialties Limited conducted its 37th Annual General Meeting on August 4, 2026. Shareholders considered agenda items including a Re. 1 dividend and related party transactions.
Resonance Specialties Ltd reported revenue from operations of ₹32.6 Cr (+53.1% YoY) and net profit of ₹5.7 Cr (+256.2% YoY) for Q1 FY27.
Resonance Specialties Limited has scheduled a Board Meeting on August 4, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Resonance Specialties issued letters to shareholders without registered email addresses regarding Annual Report access. The 37th AGM is scheduled for August 4, 2026.
Resonance Specialties Ltd filed its FY 2025-26 annual report, reporting total income of ₹91.89 Cr. The filing also announced the AGM scheduled for 4 Aug 2026.
Resonance Specialties Ltd. will hold its 37th AGM on August 4, 2026, via VC/OAVM. A dividend of Re. 1 per share is recommended, subject to approval.
Resonance Specialties Ltd set July 28, 2026, as record date for a potential Re. 1/- per share dividend. Payment will follow AGM approval and occur by August 28, 2026.
Resonance Specialties Ltd reported revenue from operations of ₹24.5 Cr (+1.2% YoY) and net profit of ₹4.6 Cr (+48.4% YoY) for Q4 FY26.
Resonance Specialties reported audited FY26 results and recommended a Re. 1 per share dividend. Net profit for the year rose significantly to ₹10.40 Crore.
Resonance Specialties Ltd has scheduled a Board Meeting for May 14, 2026. The board will consider audited financial results for Q4 and FY26, and recommend a dividend. Additionally, the trading window for insiders remains closed from March 31, 2026, until 48 hours after the results declaration.
Resonance Specialties Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The Registrar and Share Transfer Agent, Adroit Corporate Services, confirmed that share certificates received for dematerialisation were processed and cancelled within the prescribed 15-day timeline.